stockrowMarpai, Inc. (MRAI) vs Progyny, Inc. (PGNY)
- Marpai, Inc. MRAI 2.73 −2.15%
- Progyny, Inc. PGNY 34.84 +1.37%
Marpai, Inc. and Progyny, Inc. are both Healthcare Plans companies. Progyny, Inc. is the larger, with a market value of $2.6B against $5.2M — 511.6× the size. Marpai, Inc. has negative trailing earnings, so its P/E is not meaningful; Progyny, Inc. trades at 30.1×. Progyny, Inc. grew revenue faster over the last twelve months: 5.52% against −29.7%. Progyny, Inc. has the higher net margin (6.80% vs −101.5%) and the higher return on invested capital (36.0% vs 0.00%). Across the 17 metrics below, Progyny, Inc. leads on 13 and Marpai, Inc. on 4.
Valuation
Profitability
| Metric | MRAI | PGNY | Healthcare Plans median |
|---|---|---|---|
| Gross margin | 25.86% | 24.87% | 19.35% |
| Operating margin | (81.83%) | 9.40% | 2.48% |
| Net margin | (101.51%) | 6.80% | 1.45% |
| Free cash flow margin | (52.33%) | 13.42% | 3.26% |
| Return on equity | 47.39% | 18.69% | 13.58% |
| Return on assets | (164.52%) | 12.38% | 3.11% |
| Return on invested capital | 0.00% | 35.99% | 5.93% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack